IL6 and gastric ulcer: DOP ameliorates gastric ulcers by inhibiting the apoptosis of gastric mucosal cells, increasing antioxidant enzyme activity in gastric tissue and serum, promoting gastric mucosal repair, reducing the expression of pro-inflammatory factors, and downregulating the transcription of IL-6 and TNF-α genes.